March 30, 2015

Health Canada Approves 1mg/vial Presentation of EGRIFTATM (tesamorelin for injection)

Theratechnologies Inc. (Theratechnologies) (TSX: TH) is pleased to announce that Health Canada has approved a Supplement to a New Drug Submission for the 1mg/vial presentation of EGRIFTATM (tesamorelin for injection).